Binder profile
ZINC33650194
Virtual-screening candidate from ZINC.
Bound to: PA3947 — DNA-binding response regulator RocR
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC33650194- UniProt (similar protein)
Q9HX69- Tanimoto
- 0.613
- Target protein
- PA3947
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 320.2
- LogP ≤ 5 -1.66
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 172.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
NC(=O)c1ncn([C@@H]2O[C@@H]3CO[P@](=O)(O)O[C@@H]3[C@H]2O)c1NNC(=O)c1ncn([C@@H]2O[C@@H]3CO[P@](=O)(O)O[C@@H]3[C@H]2O)c1N
InChI=1S/C9H13N4O7P/c10-7-4(8(11)15)12-2-13(7)9-5(14)6-3(19-9)1-18-21(16,17)20-6/h2-3,5-6,9,14H,1,10H2,(H2,11,15)(H,16,17)/t3-,5-,6+,9-/m1/s1InChI=1S/C9H13N4O7P/c10-7-4(8(11)15)12-2-13(7)9-5(14)6-3(19-9)1-18-21(16,17)20-6/h2-3,5-6,9,14H,1,10H2,(H2,11,15)(H,16,17)/t3-,5-,6+,9-/m1/s1
QQDWJBYNAORJHB-FJFJXFQQSA-NQQDWJBYNAORJHB-FJFJXFQQSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- C2E
- Homolog
- Q9HX69
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC33650194 →
- ZINC ZINC20 ZINC33650194 →
- UniProt UniProt Q9HX69 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC33650194”) →
Other binders for this protein
Quick navigation to other ligands bound to PA3947.
ChEMBL 3
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).